過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Overactive Bladder Treatment Market Insights and Forecast to 2028

• レポートコード：QY2203B08096 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（OAB）治療の世界市場のxxx％を占める「治療薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「特発性過活動膀胱」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の過活動膀胱（OAB）治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの過活動膀胱（OAB）治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの過活動膀胱（OAB）治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 過活動膀胱（OAB）治療のグローバル主要メーカーには、Allergan、Astellas Pharma、Pfizer、Johnson & Johnson、Medtronic、KYORIN Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 過活動膀胱（OAB）治療市場は、種類と用途によって区分されます。世界の過活動膀胱（OAB）治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 治療薬、医療機器 【用途別セグメント】 特発性過活動膀胱、神経原性過活動膀胱 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 過活動膀胱（OAB）治療製品概要 - 種類別市場（治療薬、医療機器） - 用途別市場（特発性過活動膀胱、神経原性過活動膀胱） - 調査の目的 ・エグゼクティブサマリー - 世界の過活動膀胱（OAB）治療販売量予測2017-2028 - 世界の過活動膀胱（OAB）治療売上予測2017-2028 - 過活動膀胱（OAB）治療の地域別販売量 - 過活動膀胱（OAB）治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別過活動膀胱（OAB）治療販売量 - 主要メーカー別過活動膀胱（OAB）治療売上 - 主要メーカー別過活動膀胱（OAB）治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（治療薬、医療機器） - 過活動膀胱（OAB）治療の種類別販売量 - 過活動膀胱（OAB）治療の種類別売上 - 過活動膀胱（OAB）治療の種類別価格 ・用途別市場規模（特発性過活動膀胱、神経原性過活動膀胱） - 過活動膀胱（OAB）治療の用途別販売量 - 過活動膀胱（OAB）治療の用途別売上 - 過活動膀胱（OAB）治療の用途別価格 ・北米市場 - 北米の過活動膀胱（OAB）治療市場規模（種類別、用途別） - 主要国別の過活動膀胱（OAB）治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの過活動膀胱（OAB）治療市場規模（種類別、用途別） - 主要国別の過活動膀胱（OAB）治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の過活動膀胱（OAB）治療市場規模（種類別、用途別） - 主要国別の過活動膀胱（OAB）治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の過活動膀胱（OAB）治療市場規模（種類別、用途別） - 主要国別の過活動膀胱（OAB）治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの過活動膀胱（OAB）治療市場規模（種類別、用途別） - 主要国別の過活動膀胱（OAB）治療市場規模（トルコ、サウジアラビア） ・企業情報 Allergan、Astellas Pharma、Pfizer、Johnson & Johnson、Medtronic、KYORIN Pharmaceutical ・産業チェーン及び販売チャネル分析 - 過活動膀胱（OAB）治療の産業チェーン分析 - 過活動膀胱（OAB）治療の原材料 - 過活動膀胱（OAB）治療の生産プロセス - 過活動膀胱（OAB）治療の販売及びマーケティング - 過活動膀胱（OAB）治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 過活動膀胱（OAB）治療の産業動向 - 過活動膀胱（OAB）治療のマーケットドライバー - 過活動膀胱（OAB）治療の課題 - 過活動膀胱（OAB）治療の阻害要因 ・主な調査結果

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
Market Analysis and Insights: Global Overactive Bladder Treatment Market
The global Overactive Bladder Treatment market size is projected to reach US$ 6287.9 million by 2028, from US$ 5100 million in 2021, at a CAGR of 3.0% during 2022-2028.
Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Overactive Bladder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Overactive Bladder Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Overactive Bladder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Overactive Bladder Treatment market.
Global Overactive Bladder Treatment Scope and Market Size
Overactive Bladder Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Overactive Bladder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Drugs
Device
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Company
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Overactive Bladder Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Device
1.3 Market by Application
1.3.1 Global Overactive Bladder Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Overactive Bladder Treatment Market Perspective (2017-2028)
2.2 Overactive Bladder Treatment Growth Trends by Region
2.2.1 Overactive Bladder Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Overactive Bladder Treatment Historic Market Size by Region (2017-2022)
2.2.3 Overactive Bladder Treatment Forecasted Market Size by Region (2023-2028)
2.3 Overactive Bladder Treatment Market Dynamics
2.3.1 Overactive Bladder Treatment Industry Trends
2.3.2 Overactive Bladder Treatment Market Drivers
2.3.3 Overactive Bladder Treatment Market Challenges
2.3.4 Overactive Bladder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Overactive Bladder Treatment Players by Revenue
3.1.1 Global Top Overactive Bladder Treatment Players by Revenue (2017-2022)
3.1.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Overactive Bladder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Overactive Bladder Treatment Revenue
3.4 Global Overactive Bladder Treatment Market Concentration Ratio
3.4.1 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Treatment Revenue in 2021
3.5 Overactive Bladder Treatment Key Players Head office and Area Served
3.6 Key Players Overactive Bladder Treatment Product Solution and Service
3.7 Date of Enter into Overactive Bladder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Overactive Bladder Treatment Breakdown Data by Type
4.1 Global Overactive Bladder Treatment Historic Market Size by Type (2017-2022)
4.2 Global Overactive Bladder Treatment Forecasted Market Size by Type (2023-2028)
5 Overactive Bladder Treatment Breakdown Data by Application
5.1 Global Overactive Bladder Treatment Historic Market Size by Application (2017-2022)
5.2 Global Overactive Bladder Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Overactive Bladder Treatment Market Size (2017-2028)
6.2 North America Overactive Bladder Treatment Market Size by Type
6.2.1 North America Overactive Bladder Treatment Market Size by Type (2017-2022)
6.2.2 North America Overactive Bladder Treatment Market Size by Type (2023-2028)
6.2.3 North America Overactive Bladder Treatment Market Share by Type (2017-2028)
6.3 North America Overactive Bladder Treatment Market Size by Application
6.3.1 North America Overactive Bladder Treatment Market Size by Application (2017-2022)
6.3.2 North America Overactive Bladder Treatment Market Size by Application (2023-2028)
6.3.3 North America Overactive Bladder Treatment Market Share by Application (2017-2028)
6.4 North America Overactive Bladder Treatment Market Size by Country
6.4.1 North America Overactive Bladder Treatment Market Size by Country (2017-2022)
6.4.2 North America Overactive Bladder Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Overactive Bladder Treatment Market Size (2017-2028)
7.2 Europe Overactive Bladder Treatment Market Size by Type
7.2.1 Europe Overactive Bladder Treatment Market Size by Type (2017-2022)
7.2.2 Europe Overactive Bladder Treatment Market Size by Type (2023-2028)
7.2.3 Europe Overactive Bladder Treatment Market Share by Type (2017-2028)
7.3 Europe Overactive Bladder Treatment Market Size by Application
7.3.1 Europe Overactive Bladder Treatment Market Size by Application (2017-2022)
7.3.2 Europe Overactive Bladder Treatment Market Size by Application (2023-2028)
7.3.3 Europe Overactive Bladder Treatment Market Share by Application (2017-2028)
7.4 Europe Overactive Bladder Treatment Market Size by Country
7.4.1 Europe Overactive Bladder Treatment Market Size by Country (2017-2022)
7.4.2 Europe Overactive Bladder Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Overactive Bladder Treatment Market Size (2017-2028)
8.2 Asia-Pacific Overactive Bladder Treatment Market Size by Type
8.2.1 Asia-Pacific Overactive Bladder Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Overactive Bladder Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Overactive Bladder Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Overactive Bladder Treatment Market Size by Application
8.3.1 Asia-Pacific Overactive Bladder Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Overactive Bladder Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Overactive Bladder Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Overactive Bladder Treatment Market Size by Region
8.4.1 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Overactive Bladder Treatment Market Size (2017-2028)
9.2 Latin America Overactive Bladder Treatment Market Size by Type
9.2.1 Latin America Overactive Bladder Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Overactive Bladder Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Overactive Bladder Treatment Market Share by Type (2017-2028)
9.3 Latin America Overactive Bladder Treatment Market Size by Application
9.3.1 Latin America Overactive Bladder Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Overactive Bladder Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Overactive Bladder Treatment Market Share by Application (2017-2028)
9.4 Latin America Overactive Bladder Treatment Market Size by Country
9.4.1 Latin America Overactive Bladder Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Overactive Bladder Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Overactive Bladder Treatment Market Size (2017-2028)
10.2 Middle East & Africa Overactive Bladder Treatment Market Size by Type
10.2.1 Middle East & Africa Overactive Bladder Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Overactive Bladder Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Overactive Bladder Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Overactive Bladder Treatment Market Size by Application
10.3.1 Middle East & Africa Overactive Bladder Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Overactive Bladder Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Overactive Bladder Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Overactive Bladder Treatment Market Size by Country
10.4.1 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Overactive Bladder Treatment Introduction
11.1.4 Allergan Revenue in Overactive Bladder Treatment Business (2017-2022)
11.1.5 Allergan Recent Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Overactive Bladder Treatment Introduction
11.2.4 Astellas Pharma Revenue in Overactive Bladder Treatment Business (2017-2022)
11.2.5 Astellas Pharma Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Overactive Bladder Treatment Introduction
11.3.4 Pfizer Revenue in Overactive Bladder Treatment Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Overactive Bladder Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Overactive Bladder Treatment Introduction
11.5.4 Medtronic Revenue in Overactive Bladder Treatment Business (2017-2022)
11.5.5 Medtronic Recent Developments
11.6 KYORIN Pharmaceutical
11.6.1 KYORIN Pharmaceutical Company Details
11.6.2 KYORIN Pharmaceutical Business Overview
11.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Introduction
11.6.4 KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2017-2022)
11.6.5 KYORIN Pharmaceutical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Overactive Bladder Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drugs
Table 3. Key Players of Device
Table 4. Global Overactive Bladder Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Overactive Bladder Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Overactive Bladder Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Overactive Bladder Treatment Market Share by Region (2017-2022)
Table 8. Global Overactive Bladder Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Overactive Bladder Treatment Market Share by Region (2023-2028)
Table 10. Overactive Bladder Treatment Market Trends
Table 11. Overactive Bladder Treatment Market Drivers
Table 12. Overactive Bladder Treatment Market Challenges
Table 13. Overactive Bladder Treatment Market Restraints
Table 14. Global Overactive Bladder Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Overactive Bladder Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Overactive Bladder Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2021)
Table 17. Ranking of Global Top Overactive Bladder Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Overactive Bladder Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Overactive Bladder Treatment Product Solution and Service
Table 21. Date of Enter into Overactive Bladder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Overactive Bladder Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Overactive Bladder Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Overactive Bladder Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Overactive Bladder Treatment Revenue Share by Application (2017-2022)
Table 29. Global Overactive Bladder Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Overactive Bladder Treatment Revenue Share by Application (2023-2028)
Table 31. North America Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Overactive Bladder Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Overactive Bladder Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Overactive Bladder Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Overactive Bladder Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Overactive Bladder Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Overactive Bladder Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Overactive Bladder Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Overactive Bladder Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Overactive Bladder Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Overactive Bladder Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Overactive Bladder Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Overactive Bladder Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Allergan Company Details
Table 62. Allergan Business Overview
Table 63. Allergan Overactive Bladder Treatment Product
Table 64. Allergan Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 65. Allergan Recent Developments
Table 66. Astellas Pharma Company Details
Table 67. Astellas Pharma Business Overview
Table 68. Astellas Pharma Overactive Bladder Treatment Product
Table 69. Astellas Pharma Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 70. Astellas Pharma Recent Developments
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Overactive Bladder Treatment Product
Table 74. Pfizer Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Overactive Bladder Treatment Product
Table 79. Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 80. Johnson & Johnson Recent Developments
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Overactive Bladder Treatment Product
Table 84. Medtronic Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 85. Medtronic Recent Developments
Table 86. KYORIN Pharmaceutical Company Details
Table 87. KYORIN Pharmaceutical Business Overview
Table 88. KYORIN Pharmaceutical Overactive Bladder Treatment Product
Table 89. KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 90. KYORIN Pharmaceutical Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Overactive Bladder Treatment Market Share by Type: 2021 VS 2028
Figure 2. Drugs Features
Figure 3. Device Features
Figure 4. Global Overactive Bladder Treatment Market Share by Application: 2021 VS 2028
Figure 5. Idiopathic Overactive Bladder Case Studies
Figure 6. Neurogenic Overactive Bladder Case Studies
Figure 7. Overactive Bladder Treatment Report Years Considered
Figure 8. Global Overactive Bladder Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Overactive Bladder Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Overactive Bladder Treatment Market Share by Region: 2021 VS 2028
Figure 11. Global Overactive Bladder Treatment Market Share by Players in 2021
Figure 12. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Overactive Bladder Treatment Revenue in 2021
Figure 14. North America Overactive Bladder Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Overactive Bladder Treatment Market Size Market Share by Type (2017-2028)
Figure 16. North America Overactive Bladder Treatment Market Size Market Share by Application (2017-2028)
Figure 17. North America Overactive Bladder Treatment Market Size Share by Country (2017-2028)
Figure 18. United States Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Overactive Bladder Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Overactive Bladder Treatment Market Size Market Share by Type (2017-2028)
Figure 22. Europe Overactive Bladder Treatment Market Size Market Share by Application (2017-2028)
Figure 23. Europe Overactive Bladder Treatment Market Size Share by Country (2017-2028)
Figure 24. Germany Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Overactive Bladder Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Overactive Bladder Treatment Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Overactive Bladder Treatment Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Overactive Bladder Treatment Market Size Share by Region (2017-2028)
Figure 34. China Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Overactive Bladder Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Overactive Bladder Treatment Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Overactive Bladder Treatment Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Overactive Bladder Treatment Market Size Share by Country (2017-2028)
Figure 44. Mexico Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Overactive Bladder Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Overactive Bladder Treatment Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Overactive Bladder Treatment Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Overactive Bladder Treatment Market Size Share by Country (2017-2028)
Figure 50. Turkey Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Allergan Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 54. Astellas Pharma Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 55. Pfizer Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 56. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 57. Medtronic Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 58. KYORIN Pharmaceutical Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

---